Daxor (DXR) News Today $9.45 -0.47 (-4.74%) As of 08/1/2025 03:12 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Daxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility AdoptionsJuly 22, 2025 | globenewswire.comDaxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart JournalMay 14, 2025 | globenewswire.comDaxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare SystemsMay 13, 2025 | globenewswire.comDaxor Corporation Launches ezBVA Lab Service to Transform Fluid Management in Florida Healthcare FacilitiesMay 9, 2025 | nasdaq.comFlorida Healthcare Leader Embraces Daxor Blood Volume Analysis TechnologyMay 7, 2025 | globenewswire.comThree New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical AcceptanceMay 6, 2025 | globenewswire.comDaxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific SessionsApril 22, 2025 | globenewswire.comDaxor to showcase blood volume analysis at Cardiovascular Transforum conferenceApril 18, 2025 | markets.businessinsider.comDaxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025April 17, 2025 | globenewswire.comDaxor announces new data at ACC on blood volume analysisApril 16, 2025 | markets.businessinsider.comNew Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better SurvivalApril 15, 2025 | globenewswire.comDaxor Submits 510(k) To FDA For Next-Gen Blood Volume AnalyzerApril 11, 2025 | nasdaq.comDaxor announces submission of Daxor BVA to FDAApril 10, 2025 | markets.businessinsider.comDaxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume AnalyzerApril 10, 2025 | finance.yahoo.comMichael Richard Feldschuh Buys 2,063 Shares of Daxor Co. (NASDAQ:DXR) StockApril 8, 2025 | insidertrades.comDaxor announces new data from Duke University on BVA at ACCApril 2, 2025 | markets.businessinsider.comDaxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and ExpoApril 2, 2025 | globenewswire.comDaxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare NetworksMarch 28, 2025 | globenewswire.comDaxor Co. (NASDAQ:DXR) CEO Buys $25,804.80 in StockMarch 12, 2025 | insidertrades.comDaxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | msn.comEarnings call transcript: Daxor Q4 2024 sees 116.5% revenue growthMarch 8, 2025 | investing.comDaxor Corporation (DXR) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024March 4, 2025 | globenewswire.comDaxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025March 4, 2025 | globenewswire.comDaxor reports increase in NAV to $7.25 per shareMarch 4, 2025 | markets.businessinsider.comDaxor issues letter to shareholdersMarch 4, 2025 | markets.businessinsider.comDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersMarch 4, 2025 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersMarch 4, 2025 | globenewswire.comDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023March 4, 2025 | globenewswire.comDaxor Expands Blood Volume Analysis Services at Major Midwest Healthcare CenterFebruary 28, 2025 | globenewswire.comDaxor expands blood volume analysis technology to New Jersey hospitalsFebruary 27, 2025 | markets.businessinsider.comDaxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey HospitalsFebruary 27, 2025 | globenewswire.comDaxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025February 19, 2025 | globenewswire.comTruLite Health Bolsters Health Equity Expertise with Expanded Leadership TeamFebruary 18, 2025 | businesswire.comDaxor to Exhibit at World's Largest Critical Care ConferenceFebruary 18, 2025 | globenewswire.comDaxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted TreatmentFebruary 14, 2025 | globenewswire.comNew Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure CareFebruary 13, 2025 | markets.businessinsider.comDaxor Hikeson Blood StudyFebruary 13, 2025 | baystreet.caDaxor announces study published on its Blood Volume AnalysisFebruary 13, 2025 | markets.businessinsider.comNew Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure CareFebruary 13, 2025 | globenewswire.comDaxor Expands Its BVA-100™ Blood Volume Diagnostic to Two New Hospital Systems Adding to Sales MomentumDecember 18, 2024 | globenewswire.comDaxor Corporation Common Stock (DXR) SEC FilingsDecember 14, 2024 | nasdaq.comDAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24October 9, 2024 | globenewswire.comDaxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | globenewswire.comDaxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic DeviceSeptember 27, 2024 | globenewswire.comDaxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024September 19, 2024 | globenewswire.comLeading Central Florida Hospital Implements Daxor's BVA-100™ Blood Volume Diagnostic for Heart Failure Patient CareSeptember 4, 2024 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder LetterSeptember 3, 2024 | globenewswire.comDaxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comDaxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated NetworkAugust 29, 2024 | globenewswire.com Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address DXR Media Mentions By Week DXR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXR News Sentiment▼0.000.63▲Average Medical News Sentiment DXR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXR Articles This Week▼01▲DXR Articles Average Week Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sight Sciences News TriSalus Life Sciences News Inogen News Profound Medical News KORU Medical Systems News Biosig Technologies News LENSAR News Electromed News Pro-Dex News Avita Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DXR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
